MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.
On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.
Read on for the entire announcement here.
Apr 19, 2024
Tuesday’s federal Budget contained a modest increase to Canada’s investment in humanitarian assistance. This was welcomed by Canadian civil society organizations, and was especially good to... Read more
Apr 12, 2024
“Canada’s ongoing support for gender equality, the empowerment of women and girls, a greener economy and economic resilience in Africa is unwavering. My recent visit to Benin and the Democratic... Read more
Apr 10, 2024
The European Court of Human Rights (ECHR) ruled on Tuesday in favour of a group of more than 2000 older women from Switzerland who had argued that their government's inadequate efforts to combat... Read more